10.10.18
BGG and its affiliates Solix Algredients (Solix) and Algae Health Sciences (AlgaeHealth) unveiled that its flagship product, AstaZine Natural Astaxanthin, has been released in a water dispersible emulsion form for use in drink applications. This product features a new technological platform trademarked as Dispersa that will be used for other BGG products in the future.
This innovative technology resolves two key complications common in competitive “water dispersible” astaxanthin products: ineffective dispersion in water applications and residual staining of consumers’ mouths and packaging containers. “We’ve seen competitive products claiming to be water dispersible which have sedimentation and suspended particles after mixing,” said Lixin Ding, PhD, General Manager of BGG North America. “Astaxanthin using Dispersa technology is completely transparent and stable over time with no aggregation, sedimentation or suspension of Astaxanthin.”
This product was developed in Switzerland under the direction of BGG Europe’s CEO Christian Artaria who decided to begin with astaxanthin due to a lack of performance in this category.
“We’re extremely enthusiastic about this state-of-the-art development,” said Mr. Artaria. “Astaxanthin is an ideal ingredient for several different applications that lend themselves to a drinkable delivery method, such as sports drinks and anti-aging health shots. Now we can offer a truly suitable solution for pioneering brands to bring the benefits of Astaxanthin to their consumers in drinkable form.”
This innovative technology resolves two key complications common in competitive “water dispersible” astaxanthin products: ineffective dispersion in water applications and residual staining of consumers’ mouths and packaging containers. “We’ve seen competitive products claiming to be water dispersible which have sedimentation and suspended particles after mixing,” said Lixin Ding, PhD, General Manager of BGG North America. “Astaxanthin using Dispersa technology is completely transparent and stable over time with no aggregation, sedimentation or suspension of Astaxanthin.”
This product was developed in Switzerland under the direction of BGG Europe’s CEO Christian Artaria who decided to begin with astaxanthin due to a lack of performance in this category.
“We’re extremely enthusiastic about this state-of-the-art development,” said Mr. Artaria. “Astaxanthin is an ideal ingredient for several different applications that lend themselves to a drinkable delivery method, such as sports drinks and anti-aging health shots. Now we can offer a truly suitable solution for pioneering brands to bring the benefits of Astaxanthin to their consumers in drinkable form.”
